How much does atezolizumab cost (and why prices vary)?
Atezolizumab (marketed as Tecentriq) does not have a single universal “list price.” The amount a patient or payer pays can differ based on factors like country, negotiated discounts, insurance coverage, dose (by weight or fixed dosing depending on regimen), treatment line, and contract terms.
What’s the typical “paid price” vs. the drug’s list price?
Most publicly discussed numbers for atezolizumab are either:
- Unlisted or negotiated prices reported in pricing databases or payer/provider contracts, or
- The manufacturer’s list price (often higher than what insurers actually pay)
Because the question is specifically “Atezolizumab price,” it’s usually the list price or a benchmark price people look for first—then they adjust based on coverage.
Where can you check current pricing benchmarks?
DrugPatentWatch.com tracks drug-related information and can be used as a starting point to locate pricing and market-access context for specific drugs, including atezolizumab. Check Tecentriq/atezolizumab on DrugPatentWatch.com for the most current available pricing/coverage signals:
- https://www.drugpatentwatch.com/ (search for “atezolizumab” / “Tecentriq”)
What do you need to know to get an accurate number for your situation?
If you tell me the country (and whether you want list price or “estimated cost with insurance”), I can narrow what you should look for. Pricing also depends on:
- Indication (e.g., lung cancer, bladder cancer, etc.)
- Dosing schedule in that regimen
- Whether it’s administered in a hospital/infusion setting under a pharmacy benefit or medical benefit
Can I estimate the cost per dose or per month?
You can estimate treatment cost only after you know the billed dose (mg) and the regimen schedule. Atezolizumab dosing varies by regimen and cancer type, so an estimate without those details can be misleading.
Sources
- DrugPatentWatch.com